Replication-deficient recombinant adenoviruses expressing the human immunodeficiency virus Env antigen can induce both humoral and CTL immune responses in mice.
An effective vaccine against infection with human immunodeficiency virus type 1 (HIV-1) is thought likely to require both a humoral and a CTL immune response. A non-replicating adenovirus vector system has been developed that can induce both a humoral and CTL response to HIV-1 envelope in mice. It i...
Main Authors: | Bruce, C, Akrigg, A, Sharpe, SA, Hanke, T, Wilkinson, G, Cranage, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1999
|
Similar Items
-
Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus Ankara.
by: Sharpe, S, et al.
Published: (2003) -
Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity.
by: Sharpe, S, et al.
Published: (2001) -
Humoral immune responses to adenovirus vectors in the brain.
by: Kajiwara, K, et al.
Published: (2000) -
Immune response in rhesus macaques after mixed modality immunisations with DNA, recombinant adenovirus and recombinant gp120 from human immunodeficiency virus type 1.
by: Vinner, L, et al.
Published: (2006) -
Exploiting glycan topography for computational design of Env glycoprotein antigenicity
by: Zhao, Peng, et al.
Published: (2018)